Forecast

The analysts' average price target is +12,87€ (+37,35%). The median is +12,87€ (+37,35%).

Buy	20
Hold	21
Sell	1

News Go to news feed

FMC stock falls sharply after results and unchanged outlook

FMC’s stock plunged in pre-market trading after the company’s adjusted operating result in the second quarter surprised positively, but it confirmed its full-year outlook. Analysts at JPMorgan and UBS warned this could lead to lower estimates for the second half of the year. Bernstein also criticized weaker treatment numbers in the U.S.; the stock lost more than eight percent on Tradegate. » More on de.investing.com
FMC hits 52-week low at $10.55 amid high debt and asset sales

FMC shares fell to a 52-week low of $10.55, down 74.28% year‑over‑year. The company carries $4.66 billion in debt and a negative free cash flow (-$219.8 million). Tessenderlo is investing $400 million for a 20% stake to help reduce debt; FMC is also selling a parcel in Delaware for about $114 million and has filed an EPA registration dossier for the herbicide Rimisoxafen. BMO Capital reiterates a "Market Perform" rating, citing planned asset sales and the 2026 outlook. » More on de.investing.com
Exane BNP downgrades FMC and halts recent stock rally

Exane BNP has downgraded FMC from “Neutral” to “Underperform”, after which the stock fell about 2.2% to just under €43. Analyst Hugo Solvet expects persistently lower treatment volumes in the US dialysis market and points to lowered consensus estimates despite share gains year-to-date. The downgrade for now ends the recovery following the recent high reached in November. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, FMC Corp has already paid 0,21€ in dividends. The last payout was in July.

Financials

In the last quarter, FMC Corp had revenue of 759.76m€ and net profit of −163.50m€

(EUR)	Jun 2026	YoY
Revenue	+759.76m	14,75%
Gross profit	+299.75m	13,26%
Net profit	−163.50m	388,92%
EBITDA	−71.76m	149,73%

Fundamentals

Metric	Value
Market capitalization	+1.20b€
Number of shares	125.23m
52-week high/low	+34,32€ - +8,54€
Dividend yield	+7,50%
Dividends TTM	+0,70€
Beta	0,41
P/E ratio	−0,51
PEG ratio	0,00
P/B ratio	+0,85
P/S ratio	+0,43

Company profile

FMC Corporation, ein Unternehmen der Agrarwissenschaften, bietet Produkte für den Pflanzenschutz, die Pflanzengesundheit und die professionelle Schädlingsbekämpfung und Rasenpflege an. Das Unternehmen entwickelt, vermarktet und verkauft chemische Pflanzenschutzmittel, darunter Insektizide, Herbizide und Fungizide, sowie biologische Produkte, Pflanzennahrung und Saatgutbehandlungsmittel, die in der Landwirtschaft zur Steigerung der Ernteerträge und -qualität durch die Bekämpfung einer Reihe von Insekten, Unkräutern und Krankheiten sowie in nicht-landwirtschaftlichen Märkten zur Schädlingsbekämpfung eingesetzt werden. Das Unternehmen vermarktet seine Produkte über seine eigene Vertriebsorganisation sowie über Allianzpartner, unabhängige Händler und Handelsvertreter. Das Unternehmen ist in Nordamerika, Lateinamerika, Europa, dem Nahen Osten, Afrika und Asien tätig. Die FMC Corporation wurde 1883 gegründet und hat ihren Hauptsitz in Philadelphia, Pennsylvania.